Hospira Vinorelbine Tartrate10 mg/1 mL Injection Vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

vinorelbine tartrate, Quantity: 13.85 mg/mL (Equivalent: vinorelbine, Qty 10 mg/mL)

可用日期:

Hospira Australia Pty Ltd

INN（国际名称）:

Vinorelbine tartrate

药物剂型:

Injection

组成:

Excipient Ingredients: water for injections

给药途径:

Intravenous

每包单位数:

1 x 1 mL vial

类:

Medicine Listed (Export Only)

处方类型:

Not scheduled. Not considered by committee

疗效迹象:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In stage III NSCLC, Vinorelbine is indicated with in combination with cisplatin.

產品總結:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

授权状态:

Listed (Export Only)

授权日期:

2008-05-05